Price, cost and value of opiate detoxification treatments - Reanalysis of data from two randomised trials

被引:22
作者
Gossop, M [1 ]
Strang, J [1 ]
机构
[1] Natl Addict Ctr, London SE5 8AF, England
关键词
D O I
10.1192/bjp.177.3.262
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Treatments in different settings have different costs. A dilemma arises if expensive treatments lead to better outcomes. Aims To investigate conflicts between the priorities of cost minimisation, clinical effectiveness, and cost-effectiveness in the detoxification of opiate addicts. Method Cost and clinical effectiveness were examined using published outcome data. The main outcome measures were: achieving a drug-free state on completion of detoxification; the economic costs of treatment. Results In terms of simple cost, in-patient detoxification is much more expensive than out-patient treatment (ratio, 24:1). With adjustment for successful outcome, the costs are almost identical (ratio, 0.9:1). Comparison of specialist and general psychiatry in-patient settings showed that even when adjusted for clinical outcomes, the specialist setting is more costly (ratio, 1.9:1), although the outcomes are better. Conclusions Naive adherence to cost and cost-containment considerations is dangerous. Discussion of treatment costs is misleading if not informed by. and adjusted for, evidence of effectiveness. This is especially important where marked differences in outcome between treatment options exist. Declaration of interest Partial funding from the Medical Research Council.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1972, PUBLIC HEALTH, DOI [DOI 10.1016/S0033-3506(02)00027-6, DOI 10.1016/S0033-3506(73)80082-4]
[2]   Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification [J].
Bearn, J ;
Gossop, M ;
Strang, J .
DRUG AND ALCOHOL DEPENDENCE, 1998, 50 (03) :227-232
[3]   Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal [J].
Bearn, J ;
Gossop, M ;
Strang, J .
DRUG AND ALCOHOL DEPENDENCE, 1996, 43 (1-2) :87-91
[4]   CIRCUMSTANCES SURROUNDING THE INITIAL LAPSE TO OPIATE USE FOLLOWING DETOXIFICATION [J].
BRADLEY, BP ;
PHILLIPS, G ;
GREEN, L ;
GOSSOP, M .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :354-359
[5]  
Central Drugs Co-ordination Unit CM 3945, 1998, TACKL DRUGS BUILD BE
[6]  
DAWE S, 1991, BRIT J ADDICT, V86, P977
[7]   A COMPARISON OF THE WITHDRAWAL RESPONSES OF HEROIN AND METHADONE ADDICTS DURING DETOXIFICATION [J].
GOSSOP, M ;
STRANG, J .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 :697-699
[8]   OPIATE WITHDRAWAL SYMPTOMS IN RESPONSE TO 10-DAY AND 21-DAY METHADONE WITHDRAWAL PROGRAMS [J].
GOSSOP, M ;
GRIFFITHS, P ;
BRADLEY, B ;
STRANG, J .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :360-363
[9]   AN INVESTIGATION OF WITHDRAWAL SYMPTOMS SHOWN BY OPIATE ADDICTS DURING AND SUBSEQUENT TO A 21-DAY INPATIENT METHADONE DETOXIFICATION PROCEDURE [J].
GOSSOP, M ;
BRADLEY, B ;
PHILLIPS, GT .
ADDICTIVE BEHAVIORS, 1987, 12 (01) :1-6
[10]   LAPSE, RELAPSE AND SURVIVAL AMONG OPIATE ADDICTS AFTER TREATMENT - A PROSPECTIVE FOLLOW-UP-STUDY [J].
GOSSOP, M ;
GREEN, L ;
PHILLIPS, G ;
BRADLEY, B .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :348-353